Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy? [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating subacromial injections of ketamine, a glutamate receptor antagonist, to reduce pain in rotator cuff tendinopathy; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Helse Møre og Romsdal HF | Conditions: Rotator Cuff Tendinitis, Chronic Pain | Phase 2, Phase 3 | Status: COMPLETED